Lille, France

Sophie Susen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Sophie Susen of Lille, France

Introduction

Sophie Susen is a remarkable inventor based in Lille, France, known for her significant contributions to the field of medical science. With a portfolio consisting of three patented innovations, her work primarily focuses on the development of advanced antibodies for the prevention and treatment of bleeding episodes.

Latest Patents

Among her latest patents, one notable invention involves an isolated monoclonal antibody that specifically binds to the D4 domain of von Willebrand factor (VWF). This innovative antibody competes with ADAMTS13 for binding and partially inhibits its degradation of VWF. The detailed structure of the antibody includes a heavy chain with a variable domain that features at least one complementarity-determining region (CDR) sequence selected from specific groups and a light chain containing designated CDR sequences. This groundbreaking invention aims to provide therapeutic solutions for patients experiencing bleeding episodes, particularly those with conditions such as aortic stenosis or those utilizing ventricular assist devices (VAD).

Career Highlights

Sophie has made significant strides in her career by working with prestigious institutions like the Institut National de la Santé et de la Recherche Médicale and Université Paris-Sud. Her innovative approach and relentless pursuit of excellence have led to her recognition in the field of biomedical research.

Collaborations

Sophie has collaborated with a number of distinguished professionals, including Antoine Rauch and Petrus Lenting. These collaborations have contributed to her successful patent portfolio and have facilitated advancements in her research area.

Conclusion

Sophie Susen embodies the spirit of innovation in the field of medical science. Her pioneering work on monoclonal antibodies provides hope for many patients suffering from bleeding disorders. As she continues to develop her inventions and expand her influence, the medical community eagerly anticipates her future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…